Engene Holdings INC. (ENGNW) — 8-K Filings

8-K Filings (17)

• enGene Holdings Inc. Files 8-K for Material Definitive Agreement — Nov 14, 2025 Risk: medium
  On November 12, 2025, enGene Holdings Inc. entered into a material definitive agreement. The company, incorporated in British Columbia, filed a Form 8-K to repo
• 8-K Filing — Nov 12, 2025
• enGene Holdings Inc. Files 8-K Report — Sep 30, 2025 Risk: low
  On September 30, 2025, enGene Holdings Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 4868 Rue Levy, Su
• enGene Holdings Inc. Files 8-K Report — Sep 3, 2025 Risk: low
  On September 3, 2025, enGene Holdings Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a R
• enGene Holdings Inc. Files 8-K on Director/Officer Changes — Jul 8, 2025 Risk: low
  On July 7, 2025, enGene Holdings Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also i
• enGene Holdings Inc. Files 8-K on Director/Officer Changes & Shareholder Votes — Jun 10, 2025 Risk: medium
  On June 10, 2025, enGene Holdings Inc. filed an 8-K report detailing several key events. The filing includes information regarding the departure and election of
• enGene Holdings Inc. Enters Material Definitive Agreement — Jun 9, 2025 Risk: medium
  On June 4, 2025, enGene Holdings Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, incorporated in British
• enGene Holdings Inc. Files 8-K: Board, Officer, and Financial Updates — Jun 4, 2025 Risk: low
  On June 3, 2025, enGene Holdings Inc. filed an 8-K report detailing changes in its board of directors and certain officers, along with updates to compensatory a
• enGene Holdings Inc. Files 8-K on Financials — Mar 10, 2025 Risk: low
  On March 10, 2025, enGene Holdings Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 4868 Rue Levy, Suite
• enGene Holdings Inc. Files Material Definitive Agreement — Dec 20, 2024 Risk: medium
  On December 20, 2024, enGene Holdings Inc. filed an 8-K report detailing a material definitive agreement. The filing does not specify the nature of the agreemen
• enGene Holdings Inc. Files 8-K: Material Agreement & Equity Sales — Oct 25, 2024 Risk: medium
  On October 24, 2024, enGene Holdings Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
• enGene Appoints New CMO, CSO; Director Departs — Oct 21, 2024 Risk: medium
  On October 16, 2024, enGene Holdings Inc. announced the appointment of Dr. Robert L. Mass as Chief Medical Officer and Dr. David L. Brown as Chief Scientific Of
• enGene Holdings Inc. Files 8-K Report — Sep 26, 2024 Risk: low
  On September 26, 2024, enGene Holdings Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a
• enGene Holdings Inc. Files 8-K with Office Location — Sep 5, 2024 Risk: low
  On September 5, 2024, enGene Holdings Inc. filed an 8-K report. The filing confirms the company's principal executive offices are located at 4868 Rue Levy, Suit
• enGene Appoints Robert Hariri CEO, Mary Ann Gray Departs Board — Jul 24, 2024 Risk: medium
  On July 22, 2024, enGene Holdings Inc. announced the appointment of Dr. Robert L. Hariri as Chief Executive Officer and a member of the Board of Directors. Dr.
• enGene Appoints New CEO, Files 8-K — May 15, 2024 Risk: medium
  On May 15, 2024, enGene Holdings Inc. filed an 8-K report detailing several key events. The company announced the appointment of Dr. Robert L. Hariri as Chief E
• enGene Reports Material Agreements, Equity Sales, Officer Changes — Feb 14, 2024 Risk: medium
  enGene Holdings Inc. filed an 8-K on February 14, 2024, reporting events that occurred on February 13, 2024. The filing details the entry into a material defini

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX